Format
Sort by
Items per page

Send to

Choose Destination

Search Tip

Sort by Best Match to display results from highest to lowest relevance to your search terms.

Try it Now

Search results

Items: 1 to 20 of 2974

1.

Optimizing everolimus exposure when combined with calcineurin inhibitors in solid organ transplantation.

van Gelder T, Fischer L, Shihab F, Shipkova M.

Transplant Rev (Orlando). 2017 Feb 27. pii: S0955-470X(16)30108-2. doi: 10.1016/j.trre.2017.02.007. [Epub ahead of print] Review.

PMID:
28279567
2.

The "pushmi-pullyu" of resistance to chloroquine in malaria.

Skrzypek R, Callaghan R.

Essays Biochem. 2017 Mar 3;61(1):167-175. doi: 10.1042/EBC20160060. Print 2017 Feb 28. Review.

PMID:
28258239
3.

Clinical Pharmacokinetics of Vemurafenib.

Zhang W, Heinzmann D, Grippo JF.

Clin Pharmacokinet. 2017 Mar 2. doi: 10.1007/s40262-017-0523-7. [Epub ahead of print] Review.

PMID:
28255850
4.

Cytochrome P450 and P-Glycoprotein-Mediated Interactions Involving African Herbs Indicated for Common Noncommunicable Diseases.

Ondieki G, Nyagblordzro M, Kikete S, Liang R, Wang L, He X.

Evid Based Complement Alternat Med. 2017;2017:2582463. doi: 10.1155/2017/2582463. Epub 2017 Jan 31. Review.

5.
6.

Clinical Pharmacokinetics of Ombitasvir.

Badri PS, Shuster DL, Dutta S, Menon RM.

Clin Pharmacokinet. 2017 Feb 22. doi: 10.1007/s40262-017-0518-4. [Epub ahead of print] Review.

PMID:
28229375
7.

Nonsteroidal anti-inflammatory drugs in clinical and experimental epilepsy.

Radu BM, Epureanu FB, Radu M, Fabene PF, Bertini G.

Epilepsy Res. 2017 Mar;131:15-27. doi: 10.1016/j.eplepsyres.2017.02.003. Epub 2017 Feb 9. Review.

PMID:
28212985
8.

Renal Drug Transporters and Drug Interactions.

Ivanyuk A, Livio F, Biollaz J, Buclin T.

Clin Pharmacokinet. 2017 Feb 16. doi: 10.1007/s40262-017-0506-8. [Epub ahead of print] Review.

PMID:
28210973
9.

Multiple resistance to carcinogens and xenobiotics: P-glycoproteins as universal detoxifiers.

Efferth T, Volm M.

Arch Toxicol. 2017 Feb 7. doi: 10.1007/s00204-017-1938-5. [Epub ahead of print] Review.

PMID:
28175954
10.

Exploration of Molecular Targets in the Development of New Therapeutics Aimed at Overcoming Multidrug Resistance.

Nishida S, Tsubaki M.

Yakugaku Zasshi. 2017;137(2):145-149. doi: 10.1248/yakushi.16-00229-5.

11.

The Role of Eukaryotic and Prokaryotic ABC Transporter Family in Failure of Chemotherapy.

El-Awady R, Saleh E, Hashim A, Soliman N, Dallah A, Elrasheed A, Elakraa G.

Front Pharmacol. 2017 Jan 10;7:535. doi: 10.3389/fphar.2016.00535. eCollection 2017 Jan 10. Review.

12.

An Appraisal of Drug-Drug Interactions with Green Tea (Camellia sinensis).

Albassam AA, Markowitz JS.

Planta Med. 2017 Jan 24. doi: 10.1055/s-0043-100934. [Epub ahead of print]

PMID:
28118673
13.

BCS class IV drugs: Highly notorious candidates for formulation development.

Ghadi R, Dand N.

J Control Release. 2017 Feb 28;248:71-95. doi: 10.1016/j.jconrel.2017.01.014. Epub 2017 Jan 11. Review.

PMID:
28088572
14.

Physical and biological characteristics of multi drug resistance (MDR): An integral approach considering pH and drug resistance in cancer.

Omran Z, Scaife P, Stewart S, Rauch C.

Semin Cancer Biol. 2017 Jan 8. pii: S1044-579X(17)30002-0. doi: 10.1016/j.semcancer.2017.01.002. [Epub ahead of print] Review.

PMID:
28077309
15.

Gastrointestinal interactions, absorption, splanchnic metabolism and pharmacokinetics of orally ingested phenolic compounds.

Domínguez-Avila JA, Wall-Medrano A, Velderrain-Rodríguez GR, Chen CO, Salazar-López NJ, Robles-Sánchez M, González-Aguilar GA.

Food Funct. 2017 Jan 25;8(1):15-38. doi: 10.1039/c6fo01475e. Review.

PMID:
28074953
16.

A Review of Pharmacogenetics of Antimalarials and Associated Clinical Implications.

Elewa H, Wilby KJ.

Eur J Drug Metab Pharmacokinet. 2017 Jan 9. doi: 10.1007/s13318-016-0399-1. [Epub ahead of print] Review.

PMID:
28070879
17.

Sedative Effects of Levocetirizine: A Systematic Review and Meta-Analysis of Randomized Controlled Studies.

Snidvongs K, Seresirikachorn K, Khattiyawittayakun L, Chitsuthipakorn W.

Drugs. 2017 Feb;77(2):175-186. doi: 10.1007/s40265-016-0682-0. Review.

PMID:
28070872
18.

Cardiovascular Ion Channel Inhibitor Drug-Drug Interactions with P-glycoprotein.

Ledwitch KV, Roberts AG.

AAPS J. 2017 Mar;19(2):409-420. doi: 10.1208/s12248-016-0023-y. Epub 2016 Dec 27.

PMID:
28028729
19.

ABCG2/BCRP: Specific and Nonspecific Modulators.

Peña-Solórzano D, Stark SA, König B, Sierra CA, Ochoa-Puentes C.

Med Res Rev. 2016 Dec 22. doi: 10.1002/med.21428. [Epub ahead of print] Review.

PMID:
28005280
20.

Clinical Pharmacokinetics and Pharmacodynamics of Cediranib.

Tang W, McCormick A, Li J, Masson E.

Clin Pharmacokinet. 2016 Dec 9. [Epub ahead of print] Review.

PMID:
27943222

Supplemental Content

Loading ...
Support Center